Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1994 Nov 8;91(23):10967–10971. doi: 10.1073/pnas.91.23.10967

Long-term production and delivery of human growth hormone in vivo.

M W Heartlein 1, V A Roman 1, J L Jiang 1, J W Sellers 1, A M Zuliani 1, D A Treco 1, R F Selden 1
PMCID: PMC45147  PMID: 7971993

Abstract

The application of somatic cell gene therapy to large patient populations will require the development of safe and practical approaches to the generation and characterization of genetically manipulated cells. Transkaryotic implantation is a gene therapy system based on the production of clonal strains of engineered primary and secondary cells, using non-viral methods. We demonstrate here that, on implantation, these clonal cell strains stably and reproducibly deliver pharmacologic quantities of protein for the lifetime of the experimental animals.

Full text

PDF
10967

Images in this article

10968Image
on p.10968
10970Image
on p.10970

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bouck N., Di Mayorca G. Evaluation of chemical carcinogenicity by in vitro neoplastic transformation. Methods Enzymol. 1979;58:296–302. doi: 10.1016/s0076-6879(79)58145-2. [DOI] [PubMed] [Google Scholar]
  2. Brady R. O. The sphingolipidoses. N Engl J Med. 1966 Aug 11;275(6):312–318. doi: 10.1056/NEJM196608112750606. [DOI] [PubMed] [Google Scholar]
  3. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol. 1987 Aug;7(8):2745–2752. doi: 10.1128/mcb.7.8.2745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cristofalo V. J., Sharf B. B. Cellular senescence and DNA synthesis. Thymidine incorporation as a measure of population age in human diploid cells. Exp Cell Res. 1973 Feb;76(2):419–427. doi: 10.1016/0014-4827(73)90394-7. [DOI] [PubMed] [Google Scholar]
  5. Dean M. F., Muir H., Benson P. F., Button L. R., Batchelor J. R., Bewick M. Increased breakdown of glycosaminoglycans and appearance of corrective enzyme after skin transplants in Hunter syndrome. Nature. 1975 Oct 16;257(5527):609–612. doi: 10.1038/257609a0. [DOI] [PubMed] [Google Scholar]
  6. Faria A. C., Veldhuis J. D., Thorner M. O., Vance M. L. Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin. J Clin Endocrinol Metab. 1989 Mar;68(3):535–541. doi: 10.1210/jcem-68-3-535. [DOI] [PubMed] [Google Scholar]
  7. Freedman V. H., Shin S. I. Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell. 1974 Dec;3(4):355–359. doi: 10.1016/0092-8674(74)90050-6. [DOI] [PubMed] [Google Scholar]
  8. Friedmann T., Roblin R. Gene therapy for human genetic disease? Science. 1972 Mar 3;175(4025):949–955. doi: 10.1126/science.175.4025.949. [DOI] [PubMed] [Google Scholar]
  9. GLICK S. M., ROTH J., YALOW R. S., BERSON S. A. IMMUNOASSAY OF HUMAN GROWTH HORMONE IN PLASMA. Nature. 1963 Aug 24;199:784–787. doi: 10.1038/199784a0. [DOI] [PubMed] [Google Scholar]
  10. Goldstein S. Replicative senescence: the human fibroblast comes of age. Science. 1990 Sep 7;249(4973):1129–1133. doi: 10.1126/science.2204114. [DOI] [PubMed] [Google Scholar]
  11. Groth C. G., Bergström K., Collste L., Egberg N., Högman C., Holm G., Möller E. Immunologic and plasma protein studies in a splenic homograft recipient. Clin Exp Immunol. 1972 Feb;10(2):359–365. [PMC free article] [PubMed] [Google Scholar]
  12. Kawaja M. D., Fagan A. M., Firestein B. L., Gage F. H. Intracerebral grafting of cultured autologous skin fibroblasts into the rat striatum: an assessment of graft size and ultrastructure. J Comp Neurol. 1991 May 22;307(4):695–706. doi: 10.1002/cne.903070414. [DOI] [PubMed] [Google Scholar]
  13. Lin T. H., Kirkland R. T., Sherman B. M., Kirkland J. L. Growth hormone testing in short children and their response to growth hormone therapy. J Pediatr. 1989 Jul;115(1):57–63. doi: 10.1016/s0022-3476(89)80329-4. [DOI] [PubMed] [Google Scholar]
  14. Macieira-Coelho A., Taboury F. A re-evaluation of the changes in proliferation in human fibroblasts during ageing in vitro. Cell Tissue Kinet. 1982 Mar;15(2):213–224. doi: 10.1111/j.1365-2184.1982.tb01039.x. [DOI] [PubMed] [Google Scholar]
  15. Martial J. A., Hallewell R. A., Baxter J. D., Goodman H. M. Human growth hormone: complementary DNA cloning and expression in bacteria. Science. 1979 Aug 10;205(4406):602–607. doi: 10.1126/science.377496. [DOI] [PubMed] [Google Scholar]
  16. McCormick J. J., Maher V. M. Towards an understanding of the malignant transformation of diploid human fibroblasts. Mutat Res. 1988 Jun;199(2):273–291. doi: 10.1016/0027-5107(88)90209-6. [DOI] [PubMed] [Google Scholar]
  17. Palmer T. D., Rosman G. J., Osborne W. R., Miller A. D. Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1330–1334. doi: 10.1073/pnas.88.4.1330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Peeters S., Friesen H. G. A growth hormone binding factor in the serum of pregnant mice. Endocrinology. 1977 Oct;101(4):1164–1183. doi: 10.1210/endo-101-4-1164. [DOI] [PubMed] [Google Scholar]
  19. Racker E. Bioenergetics and the problem of tumor growth. Am Sci. 1972 Jan-Feb;60(1):56–63. [PubMed] [Google Scholar]
  20. Sager R., Tanaka K., Lau C. C., Ebina Y., Anisowicz A. Resistance of human cells to tumorigenesis induced by cloned transforming genes. Proc Natl Acad Sci U S A. 1983 Dec;80(24):7601–7605. doi: 10.1073/pnas.80.24.7601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Scharfmann R., Axelrod J. H., Verma I. M. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4626–4630. doi: 10.1073/pnas.88.11.4626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Selden R. F., Howie K. B., Rowe M. E., Goodman H. M., Moore D. D. Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol Cell Biol. 1986 Sep;6(9):3173–3179. doi: 10.1128/mcb.6.9.3173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Selden R. F., Skoskiewicz M. J., Howie K. B., Russell P. S., Goodman H. M. Implantation of genetically engineered fibroblasts into mice: implications for gene therapy. Science. 1987 May 8;236(4802):714–718. doi: 10.1126/science.3472348. [DOI] [PubMed] [Google Scholar]
  24. Selden R. F., Skośkiewicz M. J., Russell P. S., Goodman H. M. Regulation of insulin-gene expression. Implications for gene therapy. N Engl J Med. 1987 Oct 22;317(17):1067–1076. doi: 10.1056/NEJM198710223171706. [DOI] [PubMed] [Google Scholar]
  25. Selden R. F., Yun J. S., Moore D. D., Rowe M. E., Malia M. A., Wagner T. E., Goodman H. M. Glucocorticoid regulation of human growth hormone expression in transgenic mice and transiently transfected cells. J Endocrinol. 1989 Jul;122(1):49–60. doi: 10.1677/joe.0.1220049. [DOI] [PubMed] [Google Scholar]
  26. St Louis D., Verma I. M. An alternative approach to somatic cell gene therapy. Proc Natl Acad Sci U S A. 1988 May;85(9):3150–3154. doi: 10.1073/pnas.85.9.3150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stiles C. D., Desmond W., Chuman L. M., Sato G., Saier M. H. Growth control of heterologous tissue culture cells in the congenitally athymic nude mouse. Cancer Res. 1976 Apr;36(4):1353–1360. [PubMed] [Google Scholar]
  28. Stone S. H. Method for Obtaining Venous Blood from the Orbital Sinus of the Rat or Mouse. Science. 1954 Jan 15;119(3081):100–100. doi: 10.1126/science.119.3081.100. [DOI] [PubMed] [Google Scholar]
  29. TODARO G. J., GREEN H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol. 1963 May;17:299–313. doi: 10.1083/jcb.17.2.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Temin H. M. Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum Gene Ther. 1990 Summer;1(2):111–123. doi: 10.1089/hum.1990.1.2-111. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES